Search
for
Sort by
Research 211–240 of 1000+
- Hair follicle stem cell replication stress drives IFI16/STING-dependent inflammation in hidradenitis suppurativa
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- ONKOLOGIA OKULISTYCZNA WCZORAJ I DZIŚ
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Immune therapies for alopecia areata: evidence and new perspectives
- Alopecia Areata: An Updated Review for 2023
- Novel potential therapeutic targets of alopecia areata
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Immunomodulatory Potential and Biocompatibility of Chitosan–Hydroxyapatite Biocomposites for Tissue Engineering
- Interleukin 6 and STAT3 regulate p63 isoform expression in keratinocytes during regeneration
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Interleukin-15 is a hair follicle immune privilege guardian
- Vitiligo—Current Treatment Options and Future Perspectives
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Non-Scarring Alopecia in Females: A Comprehensive Review